author-photo

Jose Dinis

Instituto Português de Oncologia Francisco Gentil

13

Papers

903

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Pembrolizumab (pembro) for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of phase 3 KEYNOTE-040 prior radiation treatment (RT) and disease state.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

2019 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Management of Locally Advanced Esthesioneuroblastoma in a Pregnant Woman

2019 Case reports in oncological medicine
Show All
- Source
- Cite
- Save
Citations (1)
Abstract CT115: Updated survival results of the KEYNOTE-040 study of pembrolizumab vs standard-of-care chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (18)
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (166)